Give the greatest gift and help us support leukaemia patients today and in the future
We use cookies to provide a better service. Keep browsing if you're happy with this, or read our cookie policy.
Menu
08088 010 444
Take a moment to catch up with our latest news, current campaigns and appeals.
12th December 2024
This Winter, we’re wrapping gift tags around Leukaemia Care HQ, filled with heartfelt messages of support and gratitude from those who have benefited from our vital support services.
11th November 2024
Leukaemia Care is pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patients with a FLT3 mutation now have access to quizartinib, in combination with chemotherapy, thanks to a decision made by the Scottish Medicines Consortium (SMC) today.
31st October 2024
"We welcome the increase in the NHS budget. However..." - Colin Dyer, Chief Executive at Leukaemia Care shares the charity's response.
22nd October 2024
Certain patients with myelofibrosis will have access to fedratinib to treat myelofibrosis, thanks to a decision made by the National Institute for Health and Care Excellence (NICE).
4th October 2024
Leukaemia Care and UK Masto are pleased to announce that Avapritinib (Ayvakyt©) has been approved for treating advanced systemic mastocytosis in adults in England and Wales, thanks to a decision made by the National Institute for Health and Care Excellence (NICE).
19th September 2024
Leukaemia Care is pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patients with a FLT3 mutation now have access to quizartinib, in combination with chemotherapy, thanks to a decision made by the National Institute for Health and Care Excellence (NICE) today.
12th September 2024
Read our response below.
5th September 2024
In the first half of 2024, Leukaemia Care has made a massive impact on those who have been diagnosed or living with a leukaemia diagnosis. Find out more about how we are making a difference in 2024.
2nd September 2024
Leukaemia charities highlight the urgent need to raise awareness of signs and symptoms to stop the deadly blood cancer devastating lives.
29th August 2024
Leukaemia Care is aware of a shortage of interferon alpha, a medication used by some myeloproliferative neoplasm (MPN) patients. If you are concerned or affected by this news, here is some advice based on insights we've received from MPN experts and the charity, MPN Voice.
Find a Support Group
Meet with others who have been or are going through a similar journey to you
Help & Resources
Downloadable information for patients, friends or family members at the click of a button
Newsletter Signup.
Keep in touch with Leukaemia Care
chat